ClinicalTrialsFinder

High-risk NMIBC Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC

High-risk NMIBC
Shanghai Hengrui Pharmaceutical Co., Ltd.150 enrolled1 locationNCT05410730